Budesonide — Class II drug recall D-0570-2024
Completed recall by Medisca Inc., reported 2024-07-10, distributed nationwide. CGMP Deviations and Presence of Particulate Matter: Glass
| Recall number | D-0570-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medisca Inc., Irving, TX, United States |
| Recall initiated | 2024-06-26 |
| Classified | 2024-06-28 |
| Reported by FDA | 2024-07-10 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 113 bottles |
| Reason classes | foreign material, cgmp, specification failure |
| NDC | 38779-3097-00 |
| Lot numbers | 202323/G, 202323/H |
| Expiration dates | 2026-07-31 |
Product
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Reason for recall
CGMP Deviations and Presence of Particulate Matter: Glass
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0570-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.